Litcius/Paper detail

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses

Lin Wang, Ye Xiang

2020Viruses57 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (ACE2) is the receptor that allows the entry of these two viruses into host cells, a key step in the life cycle of the pathogens. The characterization of the interactions of ACE2 with the viral spike glycoproteins and structural studies of the ACE2-binding-induced conformational changes in the viral spike glycoproteins have furthered our understanding of the entry processes of these two viruses, and these studies provide useful information that will facilitate the development of antiviral agents and vaccines to control the diseases.

Topics & Concepts

GlycoproteinCoronavirusViral entryVirologySpike (software development)BiologyViral envelopeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Angiotensin-converting enzyme 2VirusMedicineViral replicationGeneticsDiseasePathologyInfectious disease (medical specialty)ManagementEconomicsSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies
Spike Glycoprotein-Mediated Entry of SARS Coronaviruses | Litcius